- Home
- APGE vs SYM Comparison
APGE vs SYM Comparison
Compare APGE & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- SYM
- Stock Information
- Founded
- APGE 2022
- SYM 2005
- Country
- APGE United States
- SYM United States
- Employees
- APGE N/A
- SYM N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- SYM Industrial Machinery/Components
- Sector
- APGE Health Care
- SYM Industrials
- Exchange
- APGE Nasdaq
- SYM Nasdaq
- Market Cap
- APGE 3.0B
- SYM 3.1B
- IPO Year
- APGE 2023
- SYM N/A
- Fundamental
- Price
- APGE $47.25
- SYM $29.49
- Analyst Decision
- APGE Strong Buy
- SYM Buy
- Analyst Count
- APGE 5
- SYM 13
- Target Price
- APGE $75.20
- SYM $43.23
- AVG Volume (30 Days)
- APGE 366.5K
- SYM 1.1M
- Earning Date
- APGE 11-12-2024
- SYM 11-18-2024
- Dividend Yield
- APGE N/A
- SYM N/A
- EPS Growth
- APGE N/A
- SYM N/A
- EPS
- APGE N/A
- SYM N/A
- Revenue
- APGE N/A
- SYM $1,676,501,000.00
- Revenue This Year
- APGE N/A
- SYM $50.65
- Revenue Next Year
- APGE N/A
- SYM $34.63
- P/E Ratio
- APGE N/A
- SYM N/A
- Revenue Growth
- APGE N/A
- SYM 62.86
- 52 Week Low
- APGE $16.39
- SYM $17.11
- 52 Week High
- APGE $72.29
- SYM $59.82
- Technical
- Relative Strength Index (RSI)
- APGE 35.00
- SYM 49.70
- Support Level
- APGE $57.85
- SYM $27.96
- Resistance Level
- APGE $63.50
- SYM $35.23
- Average True Range (ATR)
- APGE 3.86
- SYM 1.91
- MACD
- APGE -0.90
- SYM -0.21
- Stochastic Oscillator
- APGE 4.97
- SYM 22.75
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About SYM Symbotic Inc.
Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys innovative, end-to-end technology solutions that dramatically improve supply chain operations. Symbotic also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.